These findings provide a new paradigm for decorin protein core in controlling the tumor microenvironment as a fundamental biological mechanism with great implications for curbing tumorigenic growth by the induction of novel tumor suppressor genes within the stroma and for the discovery of novel gene signatures that could eventually help clinical assessment and prognosis. The gene discussed is DCN; the disease is neoplasm.